Dr. Jain will serve as the co-PI for the RFA-FD-11-001 grant titled: Phase 2 Study of Intravenous Gallium Nitrate in the Treatment of Cystic Fibrosis. He will facilitate the successful completion of this study in several specific ways. Dr. Jain will provide principal oversight for the study at Northwestern and serve as the PI for the protocol, provide oversight for IRB and informed consent submissions, as well as facilitate research subject recruitment, data collection and adverse event reporting. He will collaborate in data analysis and reporting data that is generated from this study.
|Effective start/end date
|7/1/15 → 6/30/18
- University of Washington (UWSC8836 // 2R01FD003704-03A1)
- Food and Drug Administration (UWSC8836 // 2R01FD003704-03A1)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.